Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

With the advent of artificial intelligence (AI), the industry witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, and treatment ...

With the advent of artificial intelligence (AI), the industry witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, and treatment efficacy ...

We aimed to retrieve all antibody-related complexes from the PDB using the chosen search approach. However, we encountered a notable number of false hits in the results, prompting us to implement a ...

*Corresponding Author: Leif W. Ellisen, MGH Cancer Center, CPZN-4204, 185 Cambridge Street, Boston, MA 02114. E-mail: [email protected] Clin Cancer Res 2025;XX:XX–XX R.O. Abelman, B. Wu, and H. Barnes ...

Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...

Prolium will make a $17.5m upfront payment, with potential milestone payments totalling $502.5m. Credit: uniquepixel via Getty Images. Investment company RTW Investments has launched a new biotech ...

A free daily email with the biggest news stories of the day – and the best features from TheWeek.com Contact me with news and offers from other Future brands Receive email from us on behalf of ...

Currently, chemotherapy, targeted therapy, immunotherapy or combination therapy is the main treatment for NSCLC, but it is still inevitably faced with the challenges of acquired drug resistance and ...